Xponance, Inc. Laboratory Corp Of America Holdings Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$209.01 - $232.56 $324,174 - $360,700	1,551 Added 13.54%	13,003 $2.84 Million
Q4 2023 Jan 31, 2024	SELL	$197.69 - $227.29 $158,745 - $182,513	-803 Reduced 6.55%	11,452 $2.6 Million
Q3 2023 Oct 23, 2023	BUY	$201.05 - $221.7 $185,368 - $204,407	922 Added 8.14%	12,255 $2.46 Million
Q2 2023 Jul 13, 2023	SELL	$211.93 - $241.33 $664,400 - $756,569	-3,135 Reduced 21.67%	11,333 $2.73 Million
Q1 2023 Apr 17, 2023	BUY	$213.32 - $257.83 $738,513 - $892,607	3,462 Added 31.46%	14,468 $3.32 Million
Q4 2022 Jan 23, 2023	SELL	$203.72 - $248.97 $459,999 - $562,174	-2,258 Reduced 17.02%	11,006 $0
Q3 2022 Oct 24, 2022	BUY	$204.81 - $262.19 $233,073 - $298,372	1,138 Added 9.38%	13,264 $2.72 Million
Q2 2022 Aug 02, 2022	SELL	$213.86 - $277.87 $2.81 Million - $3.65 Million	-13,129 Reduced 51.99%	12,126 $2.84 Million
Q1 2022 Apr 20, 2022	SELL	$259.82 - $298.18 $95,613 - $109,730	-368 Reduced 1.44%	25,255 $6.66 Million
Q4 2021 Jan 31, 2022	BUY	$271.6 - $314.21 $305,821 - $353,800	1,126 Added 4.6%	25,623 $8.05 Million
Q3 2021 Nov 05, 2021	BUY	$274.82 - $308.34 $2.39 Million - $2.68 Million	8,684 Added 54.92%	24,497 $6.89 Million
Q2 2021 Aug 12, 2021	SELL	$251.87 - $278.14 $735,964 - $812,725	-2,922 Reduced 15.6%	15,813 $4.36 Million
Q1 2021 May 10, 2021	BUY	$204.88 - $255.03 $13,522 - $16,831	66 Added 0.35%	18,735 $4.78 Million
Q4 2020 Feb 11, 2021	BUY	$186.91 - $214.42 $2.65 Million - $3.04 Million	14,195 Added 317.28%	18,669 $3.8 Million
Q3 2020 Oct 26, 2020	SELL	$167.03 - $201.3 $6,013 - $7,246	-36 Reduced 0.8%	4,474 $842,000
Q2 2020 Aug 14, 2020	BUY	$113.31 - $182.44 $511,028 - $822,804	4,510 New	4,510 $749,000

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account